Ironwood Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.49M Buy
21,552
+1,691
+9% +$117K 0.72% 41
2025
Q1
$1.38M Sell
19,861
-51
-0.3% -$3.54K 0.75% 43
2024
Q4
$1.71M Buy
19,912
+176
+0.9% +$15.1K 0.85% 33
2024
Q3
$2.35M Buy
19,736
+31
+0.2% +$3.69K 1.14% 21
2024
Q2
$2.81M Sell
19,705
-125
-0.6% -$17.8K 1.5% 12
2024
Q1
$2.55M Buy
19,830
+529
+3% +$67.9K 1.24% 22
2023
Q4
$2M Buy
19,301
+461
+2% +$47.7K 1.05% 28
2023
Q3
$1.71M Sell
18,840
-948
-5% -$86.2K 1.05% 27
2023
Q2
$1.6M Sell
19,788
-1,154
-6% -$93.4K 0.92% 32
2023
Q1
$1.67M Sell
20,942
-322
-2% -$25.6K 1.04% 25
2022
Q4
$1.44M Buy
21,264
+364
+2% +$24.6K 0.95% 31
2022
Q3
$1.04M Sell
20,900
-292
-1% -$14.5K 0.73% 47
2022
Q2
$1.18M Buy
21,192
+170
+0.8% +$9.47K 0.79% 42
2022
Q1
$1.17M Sell
21,022
-1,630
-7% -$90.5K 0.63% 51
2021
Q4
$1.27M Buy
22,652
+162
+0.7% +$9.08K 0.63% 50
2021
Q3
$1.08M Buy
22,490
+20
+0.1% +$960 0.56% 59
2021
Q2
$941K Buy
22,470
+760
+4% +$31.8K 0.47% 74
2021
Q1
$732K Buy
21,710
+832
+4% +$28.1K 0.39% 93
2020
Q4
$729K Buy
20,878
+314
+2% +$11K 0.43% 82
2020
Q3
$714K Buy
20,564
+436
+2% +$15.1K 0.51% 79
2020
Q2
$659K Buy
+20,128
New +$659K 0.51% 81